Coronary Heart Disease Diagnostic Imaging Devices

Global Coronary Heart Disease Diagnostic Imaging Devices Market to Reach US$2.6 Billion by 2030

The global market for Coronary Heart Disease Diagnostic Imaging Devices estimated at US$1.9 Billion in the year 2024, is expected to reach US$2.6 Billion by 2030, growing at a CAGR of 5.4% over the analysis period 2024-2030. Computed Tomography, one of the segments analyzed in the report, is expected to record a 6.5% CAGR and reach US$1.2 Billion by the end of the analysis period. Growth in the X-Ray segment is estimated at 3.3% CAGR over the analysis period.

The U.S. Market is Estimated at US$507.2 Million While China is Forecast to Grow at 8.7% CAGR

The Coronary Heart Disease Diagnostic Imaging Devices market in the U.S. is estimated at US$507.2 Million in the year 2024. China, the world`s second largest economy, is forecast to reach a projected market size of US$516.5 Million by the year 2030 trailing a CAGR of 8.7% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.5% and 5.4% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.5% CAGR.

Global Coronary Heart Disease Diagnostic Imaging Devices Market - Key Trends & Drivers Summarized

Why Are Diagnostic Imaging Devices Crucial for Coronary Heart Disease Detection?\
Coronary heart disease (CHD) remains a leading cause of mortality worldwide, necessitating advanced diagnostic imaging technologies for early detection and intervention. Imaging devices such as echocardiography, coronary angiography, computed tomography (CT), and magnetic resonance imaging (MRI) play a critical role in assessing coronary artery conditions, detecting blockages, and evaluating heart function. The increasing prevalence of CHD due to sedentary lifestyles, unhealthy diets, and aging populations has spurred demand for more accurate, non-invasive, and real-time imaging solutions. Advancements in artificial intelligence (AI) and machine learning have also enhanced the capabilities of these devices, improving diagnostic precision and patient outcomes. As the need for early CHD detection continues to grow, imaging devices are becoming more sophisticated, with real-time analytics and portable options improving accessibility for diverse patient populations.

What Technological Innovations Are Transforming Coronary Imaging?\
The diagnostic imaging market for coronary heart disease has seen remarkable advancements, with innovations such as high-resolution CT angiography, 3D imaging, and AI-powered diagnostics. These technologies enable physicians to detect coronary artery plaque, stenosis, and myocardial perfusion with greater accuracy and less radiation exposure. The development of hybrid imaging systems that combine CT with positron emission tomography (PET) or single-photon emission computed tomography (SPECT) has further improved diagnostic accuracy. Additionally, the integration of cloud-based data sharing and telecardiology solutions is expanding the reach of advanced imaging services, particularly in remote and underserved regions. As healthcare providers seek more efficient and cost-effective diagnostic methods, these cutting-edge technologies are poised to drive substantial market growth.

How Is the Growing Prevalence of CHD Driving Market Demand?\
The increasing global burden of coronary heart disease has significantly driven demand for advanced diagnostic imaging devices. Factors such as rising obesity rates, hypertension, diabetes, and smoking-related conditions have contributed to an uptick in CHD cases, necessitating regular cardiac assessments. Governments and healthcare organizations worldwide are focusing on preventive healthcare, encouraging routine screenings and early detection through imaging diagnostics. Additionally, the expansion of healthcare infrastructure in developing economies has led to greater accessibility of imaging technologies, bolstering market growth. The push for personalized medicine and precision diagnostics has further increased the adoption of advanced imaging solutions, ensuring targeted and effective CHD treatments.

What Are the Key Growth Drivers for Coronary Imaging Devices?\
The growth in the coronary heart disease diagnostic imaging devices market is driven by several factors, including continuous technological advancements, increasing healthcare expenditure, and rising awareness of heart disease prevention. The integration of AI-powered analytics in imaging devices has enhanced diagnostic accuracy, enabling faster and more efficient disease detection. Furthermore, the increasing demand for minimally invasive and non-invasive imaging solutions has spurred innovation in computed tomography angiography (CTA) and MRI technologies. The expansion of telemedicine and remote monitoring has also created opportunities for mobile and portable imaging solutions, ensuring broader accessibility. As healthcare policies emphasize early detection and preventive cardiology, the market for coronary imaging devices is expected to witness sustained growth.

SCOPE OF STUDY:

The report analyzes the Coronary Heart Disease Diagnostic Imaging Devices market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:
Modality (Computed Tomography, X-Ray, Ultrasound, Magnetic Resonance Imaging, Nuclear Medicine); Application (Arrhythmia Application, Heart Attack Application, Heart Failure Application, Congenital Heart Conditions Application, Other Applications); End-Use (Hospitals End-Use, Diagnostic Imaging Centers End-Use, Ambulatory Surgery Centers End-Use, Other End-Uses)

Geographic Regions/Countries:
World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 44 Featured) -

• Analogic Corporation
• Boston Scientific Corporation
• Bracco Imaging S.p.A.
• Canon Inc.
• Carestream Health
• CHISON Medical Technologies Co., Ltd.
• Esaote S.p.A.
• FUJIFILM Holdings Corporation
• GE HealthCare Technologies Inc.
• HeartFlow, Inc.
• Hitachi Medical Corporation
• Hologic, Inc.
• Koninklijke Philips N.V.
• Neusoft Corporation
• Positron Corporation
• Samsung Electronics Co., Ltd.
• Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
• Shimadzu Corporation
• Siemens Healthineers AG
• Ziehm Imaging GmbH

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by artificially increasing the COGS, reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

We are diligently following expert opinions of leading Chief Economists (14,949), Think Tanks (62), Trade & Industry bodies (171) worldwide, as they assess impact and address new market realities for their ecosystems. Experts and economists from every major country are tracked for their opinions on tariffs and how they will impact their countries.

We expect this chaos to play out over the next 2-3 months and a new world order is established with more clarity. We are tracking these developments on a real time basis.

As we release this report, U.S. Trade Representatives are pushing their counterparts in 183 countries for an early closure to bilateral tariff negotiations. Most of the major trading partners also have initiated trade agreements with other key trading nations, outside of those in the works with the United States. We are tracking such secondary fallouts as supply chains shift.

To our valued clients, we say, we have your back. We will present a simplified market reassessment by incorporating these changes!

APRIL 2025: NEGOTIATION PHASE

Our April release addresses the impact of tariffs on the overall global market and presents market adjustments by geography. Our trajectories are based on historic data and evolving market impacting factors.

JULY 2025 FINAL TARIFF RESET

Complimentary Update: Our clients will also receive a complimentary update in July after a final reset is announced between nations. The final updated version incorporates clearly defined Tariff Impact Analyses.

Reciprocal and Bilateral Trade & Tariff Impact Analyses:

USA
CHINA
MEXICO
CANADA
EU
JAPAN
INDIA
176 OTHER COUNTRIES.

Leading Economists - Our knowledge base tracks 14,949 economists including a select group of most influential Chief Economists of nations, think tanks, trade and industry bodies, big enterprises, and domain experts who are sharing views on the fallout of this unprecedented paradigm shift in the global econometric landscape. Most of our 16,491+ reports have incorporated this two-stage release schedule based on milestones.

Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.